IRB Process Streamlining Expected In 21st Century Cures Bill
Executive Summary
A move toward centralized institutional review board approval of study protocols could reduce clinical trial delays; House Energy and Commerce Committee also is looking at optimizing use of real-world data in the post-market setting.
You may also be interested in...
21st Century Cures Bill Could Create More Prescriptive Rx Approval Standards For FDA
Simplified and speedier drug approval process is focus for Reps. Upton and DeGette’s upcoming legislation – but getting there may mean more congressional micromanaging over FDA’s drug approval standards.
PDUFA VI Predictions: Industry Might Pay More, Get More From User Fees
Next iteration of user fee legislation could include reducing amount of data sponsors must collect; 21st Century Cures initiative represents ‘dry run’ that could smooth agreement, Pfizer rep says.
Upton Regulatory Reform Project May Be Bigger, Bolder In Next Congress
New Senate GOP majority suggests Rep. Upton's initiatives might find greater support in that chamber.